ADI 2016 | An update on disease-modifying treatments for dementia

Doug Brown

At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from April 21–24 2016, Doug Brown, PhD, from Alzheimer’s Society, London, United Kingdom, explains there are a number of clinical trials of disease-modifying treatments for people with dementia, including the investigation of sildenafil citrate (Viagra®)-like drug for vascular dementia.

Share this video  
Similar topics